Obscure gastrointestinal bleeding due to multifocal intestinal angiosarcoma

• Intestinal angiosarcoma is a diagnostic challenge due to non-specific clinical presentation and rarity.
• The diagnosis of intestinal angiosarcoma must be considered in a patient with gastrointestinal bleeding and history of radiation therapy.
• The adjuvant therapy to intestinal angiosarcoma is not well established.

IntroductionIntestinal angiosarcomas are an extremely rare and aggressive vascular tumors, with a few cases reported in the literature.Presentation of caseA 45 years-old male arrived to our hospital with intermittent gastrointestinal bleeding presenting melena and weight loss, he has antecedent of pelvic radiotherapy ten years before admission for an unknown pelvic tumor. Emergency surgery was required because of uncontrolled bleeding and hemodynamic instability. Histopathological findings revealed a multifocal high-grade epithelioid angiosarcoma, with cells reactive for CD31, keratins CKAE 1/AE3 and factor VIII.DiscussionAngiosarcomas are aggressive tumors with a high rate of lymph node metastasis and peripheral organs. The diagnosis is difficult because it present nonspecific clinical presentation, radiological and histopathological findings. There are few reports of angiosarcoma involving the small intestine and the most common presentation are abdominal pain and gastrointestinal bleeding. There is not enough information for intestinal angiosarcoma secondary to radiation therapy, but there have been proposed criteria for diagnosis: no microscopic or clinical evidence of antecedent malignant lesion, angiosarcoma presented in the field of irradiation, long latency period between radiation and angiosarcoma and histological confirmation. We suspect our patient course with a secondary form of angiosarcoma. Therapy for bleeding angiosarcoma consists in control of bleeding and medical management to stabilize the patient. Once accomplished surgical resection is required.ConclusionWe should keep in mind this tumors as a cause of obscure intestinal bleeding in patients with medical history of radiation therapy.